Lymphoma Clinical Trials in Stanford, California
18 recruitingStanford, California
Showing 1–18 of 18 trials
Recruiting
Phase 2
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
LymphomaLymphoma, Non-HodgkinFollicular Lymphoma+1 more
Beth Israel Deaconess Medical Center35 enrolled3 locationsNCT06510361
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC700 enrolled174 locationsNCT01804686
Recruiting
Phase 2
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company65 enrolled82 locationsNCT07015242
Recruiting
Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Hodgkin Lymphoma
University College, London1,042 enrolled69 locationsNCT04685616
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Hodgkin LymphomaNon-Hodgkin LymphomaHematologic Malignancies+14 more
Center for International Blood and Marrow Transplant Research99,999 enrolled142 locationsNCT01351545
Recruiting
Phase 2
Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
Mantle Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute60 enrolled3 locationsNCT06553872
Recruiting
Phase 1Phase 2
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
Relapsed and/or Refractory B-cell Lymphoma
Kite, A Gilead Company247 enrolled14 locationsNCT04989803
Recruiting
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Lymphoma, Non-HodgkinHodgkin's Disease
Stanford University9,999 enrolled1 locationNCT00398177
Recruiting
Phase 1
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
PeproMene Bio, Inc.36 enrolled6 locationsNCT05370430
Recruiting
Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Mycosis FungoidesLymphomatoid PapulosisSezary Syndrome
Memorial Sloan Kettering Cancer Center58 enrolled8 locationsNCT03587844
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Phase 1
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
Lymphoma
Treeline Biosciences, Inc.50 enrolled5 locationsNCT06733441
Recruiting
Phase 1Phase 2
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
Acute Myeloid LeukemiaT-cell LymphomaB-cell Lymphoma
CRISPR Therapeutics290 enrolled7 locationsNCT06492304
Recruiting
A Registry for People With T-cell Lymphoma
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+27 more
Memorial Sloan Kettering Cancer Center1,000 enrolled26 locationsNCT05978141
Recruiting
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Peripheral T Cell Lymphoma
Associazione Angela Serra per la ricerca sul cancro1,000 enrolled6 locationsNCT03964480
Recruiting
Phase 2
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
LymphomaLymphoma, B-Cell
Jennifer Amengual30 enrolled2 locationsNCT06954805
Recruiting
Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
Central Nervous System LymphomaTransformed LymphomaMantle Cell Lymphoma (MCL)+5 more
Miltenyi Biomedicine GmbH248 enrolled25 locationsNCT04792489
Recruiting
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Non-Hodgkin Lymphoma
Miltenyi Biomedicine GmbH150 enrolled5 locationsNCT06116110